Skip to main content

Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study

Abstract

Vasculopathy, immunological abnormalities, and excessive tissue fibrosis are key elements in the pathogenesis of progressive systemic sclerosis (SSc). Extracorporeal shock waves (ESW) have anti-inflammatory and regenerative effects on different tissues. We hypothesized that ESW can reduce endothelial cell damage and skin fibrosis in patients with SSc. We enrolled 30 patients affected by SSc, 29 females and 1 male. Rodnan Skin Score (RSS) and Visuo-Analogical Scale (VAS) for skin wellness were performed before and immediately after ESW therapy (ESWT) and at 7, 30, 60, and 90 days after the treatment. Sonographic examination of the patients’ arms was performed before and 7, 30, 60, 90 days after treatment. Blood samples were obtained before and 30 and 60 days after treatment to measure serological levels of von Willebrand factor, vascular endothelial growth factor, intracellular adhesion molecule-1, monocyte chemotactic protein-1. The number of endothelial progenitor cells (EPCs) and circulating endothelial cells (CECs) were determined at the same time points. After ESWT we observed a rapid and persistent reduction of RSS and decrease of VAS. There was no difference in skin thickness before and after ESWT; however, we observed a more regular skin structure and an improvement in skin vascularization 90 days after treatment. EPCs and CECs increased 60 and 90 days after treatment, while serological biomarkers showed no variation before and after therapy. In conclusion, ESWT resulted in an improvement of VAS, RSS, and of skin vascular score, and in an increase of CECs and EPCs.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Abraham DJ, Varga J (2005) Scleroderma: from cell and molecular mechanisms to disease models. TRENDS Immunol 26:587–595

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Matucci Cerinic M, Valentini G, Sorano GG et al (2003) Blood coagulation, fibrinolysis and markers of endothelial dysfunction in systemic sclerosis. Arthritis Rheum 32:285–295

    Article  Google Scholar 

  3. 3.

    Carvalho JF, Blank M, Shoenfeld Y (2007) Vascular endothelial growth factor (VEGF) in autoimmune disease. J Clin Immunol 27:246–256

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Denton CP, Black CM (2005) Targeted therapy comes of age in scleroderma. TRENDS Immunol 26:596–602

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Meier R, Kamelger FS, Piza-Katzer H (2005) Shock wave therapy: an innovative treatment method for partial thickness burns. Burns 31:921–922

    Article  Google Scholar 

  6. 6.

    Mariotto S, Cavalieri E, Amelio E et al (2005) Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide 12:89–96

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Ciampa AR, Carcereri de Prati A, Amelio E et al (2005) Nitric oxide mediates anti-inflammatory action of extracorporeal shock waves. FEBS Lett 579:6839–6845

    PubMed  Article  CAS  Google Scholar 

  8. 8.

    Aicher A, Heeschen C, Sasaki K et al (2006) Low-energy shock wave for enhancing recruitment of endothelial progenitor cells. A new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 114:2823–2830

    PubMed  Article  Google Scholar 

  9. 9.

    Schaden W, Thiele R, Kölpl C et al (2007) Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. J Surg Res 143:1–12

    PubMed  Article  Google Scholar 

  10. 10.

    Rompe JD, Rumler F, Hopf C, Nafe B, Heine J (1995) Extracorporeal shock wave therapy for calcifying tendonitis of the shoulder. Clin Orthop 321:196–201

    PubMed  Google Scholar 

  11. 11.

    Haupt G, Haupt A, Ekkernkamp A, Gerety B, Chvapil M (1992) Influence of shock waves on fracture healing. Urology 39:529–532

    PubMed  Article  CAS  Google Scholar 

  12. 12.

    Rompe JD, Hopft C, Kullmer K, Heine J, Burger R, Nafe B (1996) Low energy extracorporeal shock wave therapy for persistent tennis elbow. Int Orthop 20:23–27

    PubMed  Article  CAS  Google Scholar 

  13. 13.

    Rompe JD, Hopft C, Nafe B, Burger R (1996) Low-energy extracorporeal shock wave therapy for painful heel: a prospective controlled single-blind study. Arch Orthop 115:75–79

    CAS  Google Scholar 

  14. 14.

    Nishida T, Shimokava H, Keiji O et al (2004) Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 110:3055–3061

    PubMed  Article  Google Scholar 

  15. 15.

    Romitelli F, Santini SA, Chierici E et al (2007) Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: the importance of correct removal of proteins in Griess assay. J Cromatogr B 851:257–267

    Article  CAS  Google Scholar 

  16. 16.

    Wang FS, Wang CJ, Chen YJ et al (2004) Ras induction of superoxide activates ERK-dependent angiogenic transcriptional factor HIF-1 and VEGF-A expression in shock wave-stimulated osteoblasts. J Biol Chem 279:10331–10337

    PubMed  Article  CAS  Google Scholar 

  17. 17.

    Mariotto S, Carcereri de Prati A, Cavalieri E et al (2009) Extracorporeal shock wave therapy in inflammatory diseases: molecular mechanism that triggers anti-inflammatory action. Curr Med Chem 16:2366–2372

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Urbich C, Aicher A, Heeschen C et al (2005) Soluble factors released by endothelial progenitors cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39:733–742

    PubMed  Article  CAS  Google Scholar 

  19. 19.

    Yan X, Zeng B, Chai Y, Luo C, Li X (2008) Improvement of blood flow, expression of nitric oxide, and vascular endothelial growth factor by low-energy shock wave therapy in random-pattern skin flap model. Ann Plast Surg 61:646–653

    PubMed  Article  CAS  Google Scholar 

  20. 20.

    Chen YJ, Wurtz T, Wang CJ et al (2004) Recruitment of mesenchymal cells and expression of TGF-β1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defects in rats. J Orthop Res 22:526–534

    PubMed  Article  CAS  Google Scholar 

  21. 21.

    Wang SF, Yang KD, Chen RF et al (2002) Extracorporael shock-wave promotes growth and differentiation of bone marrow stromal cells towards osteoprogenitors associated with induction of TGF-β1. J Bone Joint Surg Br 84:457–461

    PubMed  Article  CAS  Google Scholar 

  22. 22.

    Nurzynska D, Di Meglio F, Castaldo C et al (2008) Shock waves activate in vitro cultured progenitors and precursors of cardiac cell lineages from the human heart. Ultrasound Med Biol 34:334–342

    PubMed  Article  Google Scholar 

Download references

Acknowledgment

We thanks Dr. Ernst Marlinghaus for his invaluable technical support.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Claudio Lunardi.

Additional information

Elisa Tinazzi and Ernesto Amelio were equally contributed to the work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tinazzi, E., Amelio, E., Marangoni, E. et al. Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study. Rheumatol Int 31, 651–656 (2011). https://doi.org/10.1007/s00296-009-1339-z

Download citation

Keywords

  • ESWT: extracorporeal shock wave therapy
  • SSc: progressive systemic sclerosis
  • Skin fibrosis
  • Endothelial cell damage